Trial record 1 of 1 for:    NCT01573780
Previous Study | Return to List | Next Study

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01573780
Recruitment Status : Terminated (Sponsor did not have funds to continue study)
First Posted : April 10, 2012
Last Update Posted : January 15, 2014
National Cancer Institute (NCI)
TetraLogic Pharmaceuticals
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2013
  Study Completion Date : No date given